Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
KORU Medical Systems
(NASDAQ:KRMD)
Intraday
$2.14
0
[0.00%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$2.14
0
[0.00%]
Last update: 4:02PM
Get Real Time Here
Get Report
Watch
Q1 2024 Earnings in 7 days from now on Wed May 1st, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for KORU Medical Systems Stock (NASDAQ:KRMD)
KORU Medical Systems Stock (NASDAQ: KRMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 11, 2024
KORU Medical Systems Announces Successful Appeal In EU Notified Body Review
Benzinga Newsdesk
-
Apr 11, 2024, 4:08PM
Monday, March 18, 2024
KORU Medical Plans To Present Data Showing 97% Adherence On Its Freedom Infusion System For Large Volume Subcutaneous Administration At NHIA 2024 Conference
Benzinga Newsdesk
-
Mar 18, 2024, 5:25PM
Thursday, March 14, 2024
B. Riley Securities Reiterates Buy on KORU Medical Systems, Maintains $4 Price Target
Benzinga Newsdesk
-
Mar 14, 2024, 10:37AM
Wednesday, March 13, 2024
KORU Medical Systems Sees FY24 Revenue $31.2M-$32.2M Vs $32.260M Est.
Benzinga Newsdesk
-
Mar 13, 2024, 4:28PM
Recap: KORU Medical Systems Q4 Earnings
Benzinga Insights
-
Mar 13, 2024, 4:10PM
KORU Medical Systems Q4 2023 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $7.186M Beat $6.944M Estimate
Benzinga Newsdesk
-
Mar 13, 2024, 4:09PM
Earnings Scheduled For March 13, 2024
Benzinga Insights
-
Mar 13, 2024, 6:15AM
Tuesday, March 12, 2024
Earnings Outlook For KORU Medical Systems
Benzinga Insights
-
Mar 12, 2024, 12:01PM
Monday, March 11, 2024
KORU Medical Systems Announces Feasibility Study To Enter Ambulatory Infusion Settings With A Commercialized Biologic
Benzinga Newsdesk
-
Mar 11, 2024, 4:11PM
Wednesday, March 06, 2024
Koru Medical Systems Announced A Clinical Supply Agreement For A Novel Subcutaneous Immunoglobulin Drug Entering Phase 3 Trials
Benzinga Newsdesk
-
Mar 6, 2024, 7:28AM
Thursday, December 07, 2023
Canaccord Genuity Reiterates Buy on KORU Medical Systems, Maintains $3 Price Target
Benzinga Newsdesk
-
Dec 7, 2023, 10:36AM
Wednesday, November 08, 2023
KORU Medical Systems Reduces FY23 Revenue Guidance From $31M-$32.5M To $28M-$28.5M vs $31.06M Est.
Benzinga Newsdesk
-
Nov 8, 2023, 6:03PM
KORU Medical Systems, Inc. Announces Development Agreement For Next-Generation Subcutaneous Immunoglobulin Infusion System
Benzinga Newsdesk
-
Nov 8, 2023, 5:23PM
KORU Medical Systems Q3 Adj EPS $(0.03) Beats $(0.05) Estimate, Sales $7.00M Miss $7.93M Estimate
Benzinga Newsdesk
-
Nov 8, 2023, 5:04PM
Earnings Scheduled For November 8, 2023
Benzinga Insights
-
Nov 8, 2023, 4:21AM
Tuesday, November 07, 2023
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance For FREEDOM60 Infusion System With Hizentra 50 ML Prefilled Syringes
Benzinga Newsdesk
-
Nov 7, 2023, 5:14PM
Thursday, October 05, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Oct 5, 2023, 9:10AM
Thursday, September 07, 2023
Breaking The Hospital Chain: Analyst On How KORU's Self-Administered Therapies Promise 20% CAGR Through 2026
Vandana Singh
-
Sep 7, 2023, 2:27PM
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
Benzinga Insights
-
Sep 7, 2023, 11:00AM
Lake Street Initiates Coverage On KORU Medical Systems with Buy Rating, Announces Price Target of $4
Benzinga Newsdesk
-
Sep 7, 2023, 8:53AM
B. Riley Securities Initiates Coverage On KORU Medical Systems with Buy Rating, Announces Price Target of $4.5
Benzinga Newsdesk
-
Sep 7, 2023, 8:34AM
Wednesday, August 23, 2023
Massive Insider Trade At KORU Medical Systems
Benzinga Insights
-
Aug 23, 2023, 11:02AM
Wednesday, August 09, 2023
KORU Medical Systems Names Tom Adams As CFO
Benzinga Newsdesk
-
Aug 9, 2023, 5:39PM
KORU Medical Systems Sees FY23 Net Revenue $31M-$32.5M Vs $31.51M Est
Benzinga Newsdesk
-
Aug 9, 2023, 5:38PM
KORU Medical Systems Q2 Adj EPS $(0.05), Inline, Sales $6.94M Miss $7.22M Estimate
Benzinga Newsdesk
-
Aug 9, 2023, 4:10PM
Earnings Scheduled For August 9, 2023
Benzinga Insights
-
Aug 9, 2023, 4:54AM
Tuesday, August 08, 2023
Earnings Preview For KORU Medical Systems
Benzinga Insights
-
Aug 8, 2023, 2:01PM
Thursday, August 03, 2023
Piper Sandler Maintains Overweight on KORU Medical Systems, Lowers Price Target to $3
Benzinga Newsdesk
-
Aug 3, 2023, 12:43PM
Wednesday, August 02, 2023
KORU Medical Systems Sees FY23 Ne Revenues $31M-$32.5M vs $32.62M Est.
Benzinga Newsdesk
-
Aug 2, 2023, 5:39PM
KORU Medical Systems Sees Prelim. Q2 Net Revenues ~$6.9M vs $7.78M Est.
Benzinga Newsdesk
-
Aug 2, 2023, 5:39PM
Koru Medical Systems Named Thomas As CFO, Effective August 1 Replacing Andy Lafrence
Charles Gross
-
Aug 2, 2023, 5:17PM
Thursday, July 27, 2023
KORU Medical Systems Announces Novel Therapies Collaboration For Late-Stage Endocrinological Biologic
Happy Mohamed
-
Jul 27, 2023, 4:42PM
Monday, July 10, 2023
KORU Medical Reports 510(K) Submission For Freedom60 Infusion System With Hizentra 50 Ml Prefilled Syringes
Benzinga Newsdesk
-
Jul 10, 2023, 7:03AM
Thursday, May 04, 2023
KORU Medical Systems Q1 Adj EPS $(0.05), Inline, Sales $7.39M Miss $7.44M Estimate
Benzinga Newsdesk
-
May 4, 2023, 4:50PM
KORU Medical Systems Q1 EPS $(0.05), Inline, Sales $7.39M Miss $7.44M Estimate
Happy Mohamed
-
May 4, 2023, 4:50PM
Earnings Scheduled For May 4, 2023
Benzinga Insights
-
May 4, 2023, 6:34AM
Friday, March 10, 2023
Repro-Med Systems's Return On Capital Employed Overview
Benzinga Insights
-
Mar 10, 2023, 9:50AM
Wednesday, March 08, 2023
Repro-Med Systems Q4 EPS $(0.04) Beats $(0.06) Estimate, Sales $7.34M Miss $7.38M Estimate
Benzinga Newsdesk
-
Mar 8, 2023, 4:03PM
Earnings Scheduled For March 8, 2023
Benzinga Insights
-
Mar 8, 2023, 4:42AM
Tuesday, March 07, 2023
A Preview Of Repro-Med Systems's Earnings
Benzinga Insights
-
Mar 7, 2023, 11:02AM
Wednesday, January 25, 2023
KORU Medical Systems Announced Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement
Charles Gross
-
Jan 25, 2023, 7:02AM
Friday, January 06, 2023
Piper Sandler Maintains Overweight on KORU Medical Systems, Raises Price Target to $4.5
Benzinga Newsdesk
-
Jan 6, 2023, 6:56AM
Friday, December 16, 2022
Repro-Med Systems Earnings Perspective: Return On Capital Employed
Benzinga Insights
-
Dec 16, 2022, 9:45AM
Thursday, November 10, 2022
Canaccord Genuity Upgrades KORU Medical Systems to Buy, Raises Price Target to $4
Benzinga Newsdesk
-
Nov 10, 2022, 9:37AM
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
Benzinga Insights
-
Nov 10, 2022, 9:11AM
Piper Sandler Upgrades KORU Medical Systems to Overweight, Raises Price Target to $3.5
Benzinga Newsdesk
-
Nov 10, 2022, 6:15AM
Wednesday, November 09, 2022
KORU Medical Raises FY22 Revenue Outlook To $27.5M - $28.0M (Previously $27.0M - $27.5M), Vs. $27.02M Estimate
Benzinga Newsdesk
-
Nov 9, 2022, 4:51PM
Repro-Med Systems Q3 Adj. EPS $(0.03) Beats $(0.05) Estimate, Sales $7.76M Beat $6.77M Estimate
Benzinga Newsdesk
-
Nov 9, 2022, 4:48PM
Earnings Scheduled For November 9, 2022
Benzinga Insights
-
Nov 9, 2022, 4:06AM
Tuesday, November 08, 2022
KORU Medical Systems Announces Novel Therapy Collaboration For Three Indications With Kira Pharmaceuticals
Benzinga Newsdesk
-
Nov 8, 2022, 7:25AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch